Siemens and Bentley Systems Collaborate on Process Industries Academy Initiative
12.6.2018 19:44:00 EEST | Business Wire | Press release
(from ACHEMA, World Forum for the Process Industries) − Siemens’ Process Industries and Drives and Digital Factories divisions are teaming up with Bentley Systems’ Bentley Institute to establish a Process Industries Academy that will support the companies’ joint vision for cloud services and digital workflows in engineering and operations. The Process Industries Academy will help organizations to better understand and develop an effective digital strategy across all aspects of the asset lifecycle, based on the practical experience and knowledge of the industry’s leading experts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612006205/en/
The Process Industries Academy helps organizations develop digital strategy best practices based on practical knowledge from industry experts. (Photo: Bentley Systems)
With recent fluctuations in the oil, gas, and global energy markets, and the subsequent impact on related process manufacturing sectors, established ways of working in the process industries are now being challenged across the entire project lifecycle. Fewer capital investments in greenfield projects, and an increased focus on optimizing productivity, performance and utilization of existing assets, have prompted the process industries to examine new ways to increase competitiveness and operating revenues.
An optimal approach to project delivery and asset performance addresses the interactions and balance between an organization’s capabilities, its people, the underlying business processes and methods, all coupled with the latest technology, to consistently improve its business outcomes.
Based on the experience and knowledge of the industry’s leading experts, the Process Industries Academy will provide sessions focusing on real-world examples of the key aspects of a digital approach to capital project delivery and asset operations. Participants will discover how developing a clear digital strategy for improved collaboration, communication, and coordination between project teams creates an ideal environment to optimize information creation and digital workflows.
Eckard Eberle, CEO, Process Automation, Process Industries and Drives Division, Siemens AG, said, “The Process Industries Academy supports the development of industry best-practice approaches, while respecting the culture and traditions within today’s process industries. Our shared vision for the academy is to offer a practical, effective means for asset owners, decision makers, and program and project managers to understand the interactions and balance between teams, processes, and technologies so they can see improved project delivery and asset performance.”
Alan Lamont, vice president of Digital Advancement Academies for Bentley Systems, said, “The Process Industries Academy will offer industry professionals an environment to learn and share practical insights about business process improvements enabled by technology, so they can educate and equip their teams to be more productive and achieve the best outcomes. With academy sessions, we hope to help participants to develop a better understanding of their role and the benefits across the asset lifecycle, with practical, real-world examples of “Going Digital” to advance capital project delivery and asset operations.”
Process Industries Academies will be situated in the following locations to support the global process industry:
- Karlsruhe, Germany at Siemens’ Process Automation World
- Houston, Texas, U.S. in Bentley’s Digital Advancement Academy
- Shanghai, China at Siemens’ Process Industry Center of Excellence
The first academy session is scheduled for November 14, 2018 in Karlsruhe at Siemens Process Automation World. A half-day preview of the Process Industries Academy will be featured during Bentley’s Year in Infrastructure 2018 Conference in London on Monday, October 15.
Caption and image link:
The
Process Industries Academy will help organizations develop a digital
strategy based on practical experience and knowledge from leading
experts.
Attribution: Photo courtesy of Bentley Systems
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide. www.siemens.com
Bentley Institute advances the infrastructure professions by encouraging and supporting going digital. Its initiatives advance and attract current and future infrastructure professionals through continuous learning about technology solutions, as well as project delivery and asset performance best practices. Bentley Institute’s Digital Advancement Academies facilitate an environment and a culture of innovation via awareness sessions, forums, and targeted seminars and working groups, helping to ensure that all project collaborators fully understand the digital processes, standards, and deliverables expected for successful project outcomes. www.bentley.com/learn
Bentley Systems, Incorporated is a global leader dedicated to providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing infrastructure. Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, and is on track to surpass an annual revenue run rate of $700 million. Since 2012, Bentley has invested more than $1 billion in research, development, and acquisitions. www.bentley.com
Bentley and the Bentley logo are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180612006205/en/
Contact information
Bentley Systems, Incorporated
Press Contact:
Jennifer Maguire
+1
610-458-2695
jennifer.maguire@bentley.com
Follow
us on Twitter:
@BentleySystems
or
Siemens
AG
Evelyne Kadel
evelyne.kadel@siemens.com
+49
211 69161003
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
